AMETEK Declares Quarterly Dividend

The Board of Directors ofAMETEK, Inc. (NYSE: AME) declared a regular quarterly dividend of $0.31 per share for the fourth quarter ending December 31, 2025. This fourth quarter dividend is payable December 19, 2025 to shareholders of record as of December 5, 2025. Corporate Profile:AMETEK (NYSE: AME) is a leading global provider of industrial technology […]

PRM Pharma Announces Nationwide Availability of HemiClor® (Chlorthalidone) 12.5 mg: The First FDA-Approved Low-Dose Chlorthalidone Tablet Aligned With Hypertension Guidelines

PRM Pharma, LLC announces the nationwide availability of HemiClor® (chlorthalidone) 12.5 mg tablets, the first and only FDA-approved 12.5 mg formulation of chlorthalidone for the treatment of hypertension in adults (www.HemiClor.com).1 https://mma.prnewswire.com/media/2679685/New_PRM_Pharma_HemiClor_Logo.jpg This milestone comes as the newly released 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adultsreemphasizes

Pound Sterling Conversion Rate for 2025 Interim Dividend

Burford Capital Limited (“Burford”), the leading global finance and asset management firm focused on law, today announces the pound sterling conversion rate for its previously declared interim dividend for the year ending December 31, 2025 of 6.25 US cents per ordinary share to be paid on December 4, 2025 to holders of Burford's ordinary shares

Conduent Reports Third Quarter 2025 Financial Results

Conduent Reports Third Quarter 2025 Financial Results GlobeNewswire November 07, 2025 Key Q3 2025 Highlights Debt refinance completed Revenue and Adj. Revenue(1): $767M Pre-tax Income (Loss): $(38)M Adj. EBITDA Margin(1): 5.2% New Business Signings ACV(2): $111M Net ARR Activity Metric(2) (TTM): $25M FLORHAM PARK, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT),

Tom Lee’s Fundstrat Granny Shots US Large Cap ETF (NYSE: GRNY) Celebrates One-Year Anniversary — Surpasses $3.65 Billion AUM, Up 30.12% YTD, and Ranks in the Top 1% on Morningstar

Fundstrat Capital today announced the one-year anniversary of its flagship exchange-traded fund, the Fundstrat Granny Shots US Large Cap ETF (NYSE: GRNY), marking a year of rapid asset growth, strong performance, and increasing investor engagement. https://mma.prnewswire.com/media/2549573/Fundstrat_Capital_Logo.jpg Since launching on November 7, 2024, GRNY has quickly become one of the fastest-growing actively managed large-cap equity ETFs,

Trumid Extends Platform Momentum into October

Surging Trumid RFQ activity and record Investment Grade market share drive 19% YoY ADV growth Trumid, a financial technology company and leading fixed income electronic trading platform, today announced trade volume and user participation highlights for October 2025. https://mma.prnewswire.com/media/2544830/Trumid_Logo.jpg List trading protocols continued to drive growth, with combined Trumid RFQ and Portfolio Trading ADV up

Celldex to Present at Upcoming Investor Conferences

Celldex to Present at Upcoming Investor Conferences GlobeNewswire November 07, 2025 HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) — Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences: Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11 at 10:00 am ET TD Cowen Immunology & Inflammation

MAX Power Begins Historic Drilling of Canada’s First-Ever Natural Hydrogen Well

(CNSX:MAXX),(CNSX:MAXX.CN),(Pinksheets:MAXXF),(PinkSheets:MAXXF),(Boerse Frankfurt – Freiverkehr:89N.F),(Boerse Frankfurt – Freiverkehr:89N), The Lawson Target Exhibits All Five Key Elements for a Potential Natural Hydrogen Accumulation Including Source Rocks, Migration Pathways, Reservoirs, Seals and Traps, Along With a Defined Four-Way Structural Closure MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, Nov. 07, 2025 (GLOBE NEWSWIRE) — MAX Power Mining

BRAEMAR HOTELS & RESORTS ANNOUNCES SALE OF THE CLANCY

Braemar Hotels & Resorts Inc. (NYSE: BHR) (“Braemar” or the “Company”) announced today that it has closed on the previously announced sale of the 410-room The Clancy in San Francisco for $115 million ($280,487 per key). The sale price represents a 5.2% capitalization rate on net operating income for the trailing 12 months ended September

Dupixent(R) (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review

(NASDAQ:REGN), Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years and older compared to placebo Dupixent sBLA accepted for priority review by the U.S. FDA with a target action date of February 28, 2026

Scroll to Top